Search

everythinglearnresearchcommunity

for

Search:↓

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Early diagnosis and treatment are crucial for managing Berardinelli–Seip syndrome.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Modified laparoscopic sleeve gastrectomy effectively controls diabetes and treats obesity with minimal complications.

The flutamide-loaded hydrogel is a promising, skin-friendly treatment for acne and hair loss, potentially requiring less frequent application.

Linagliptin may cause hair loss and skin blisters.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Anti-CD19 therapy may help treat SLE and NMOSD.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Adalimumab improved folliculitis decalvans in most patients.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

Mogamulizumab can cause hair loss and skin rashes.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.